New technology designed to speed dystrophin measurement while ensuring consistency Automation of dystrophin measurement will aid development of Sarepta’s Duchenne muscular dystrophy candidates Cambridge, Mass. - Aug 20, 2014 - Sarepta Therapeutics, Inc, a developer of...
News and Insights from Our Multidisciplinary Team of Experts
Sign up to receive industry and company news, including The Cut Point, Flagship’s quarterly e-newsletter.
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
WORLD CB AND CDX BOSTON 2019 (CLINICAL BIOMARKER AND COMPANION DIAGNOSTICS)September 9-12, 2019 The Renaissance Boston Waterfront, Boston, MA Flagship Biosciences is a proud Spotlight Partner of World CB and CDx Boston 2019. Flagship’s leaders will be speaking and...